胃镜下胃内水球置入治疗肥胖症的麻醉处理  

The anesthesia of intragastric balloon for treatment of morbid obesity

作　　者：李集慧[1] 汤深[2] 徐恩斌[3] 陈海莲[1] 鞠衍馨[1] 王猛[1] 

机构地区：[1]解放军第404医院麻醉科,山东威海264200 [2]青岛大学医学院外科总论教研室,山东青岛266071 [3]解放军第404医院消化内科,山东威海264200

出　　处：《中国内镜杂志》2013年第11期1211-1213,共3页China Journal of Endoscopy

摘　　要：目的探讨胃镜下胃内水球置入治疗肥胖症的麻醉方法及其安全性。方法132例肥胖症患者实施胃内水球置入或取出，均采用静脉注射地佐辛60～70μg／kg，丙泊酚2～2．5mg／kg，待睫毛反射消失后手术开始，术中以丙泊酚4mg／（kg．h）维持麻醉。结果所有患者均顺利实施了胃镜下水球置入或取出，仅1例患者因窒息实施气管插管，无后遗症。结论丙泊酚一地佐辛静脉复合麻醉适用于肥胖症患者的胃内水球治疗。[ Objective ] To evaluate efficiency and safety of propofol-dezocine applied to anesthesia of intragas- tric balloon for treatment of morbid obesity. [Methods ] 132 patients scheduled for treatment of morbid obesity were given dezocine 60-70p, g/kg and propofol 2-2.5mg by intravenous for anesthesia. At loss of eye-lash reflex the pro- cedure started. The anesthesia was maintained with propofol 4mg/kg/h continuously during the operation. [ Results ] All patients were successfully completed. Only one patient was intubated because of asphyxia, but there had no com- plication in the patient. [ Conclusions ] The combination of propofol with dezocine applied to anesthesia is fit for intragastric balloon for treatment of morbid obesity.

关 键 词：肥胖症 胃内水球 胃镜 静脉复合麻醉 丙泊酚 地佐辛 

分 类 号：R589.2[医药卫生—内分泌]